Table 5.
Group 1 Norethisterone Acetate 5 mg | Group 2 Doubling Dose | Group 3 No Change | Group 4 Switching Type | p-Value | |
---|---|---|---|---|---|
No adverse effect | 26 (77%) | 14 (82%) | 39 (85%) | 5 (83%) | 0.198 |
Decreased libido | 4 (12%) | 0 (0%) | 2 (4%) | 0 (0%) | |
Headache/abdominal pain/dizziness | 0 (0%) | 0 (0%) | 1 (2%) | 0 (0%) | |
Mood swings/depression/fatigue | 3 (9%) | 2 (12%) | 2 (4%) | 1 (17%) | |
No change in breastfeeding | 25 (73%) | 12 (70%) | 43 (94%) | 5 (83%) | 0.083 |
Decreased in breastfeeding | 8 (24%) | 3 (18%) | 3 (6%) | 1 (17%) | |
Stopped breastfeeding | 1 (3%) | 2 (11%) | 0 (0%) | 0 (0%) |